RNP Antibody Test

The RNP antibody is an autoantibody made by the immune system that mistakenly attacks certain proteins inside the cell’s nucleus. These proteins are part of a structure called the U1 small nuclear ribonucleoprotein (U1 snRNP), which plays an essential role in processing genetic information by editing RNA before it is used to make proteins.

The U1 snRNP is a complex made up of both proteins and RNA. It is crucial for a process called RNA splicing, where the initial genetic instructions (pre-messenger RNA) are trimmed and stitched together to create a final message the cell can understand. The RNP antibodies target specific proteins in the U1 snRNP, known as the 70-kD, A, and C proteins, which are only found in this particular complex. When these proteins are attacked, it can disrupt normal cell function and trigger inflammation.

The RNP antibody is important because it appears in several autoimmune diseases. It is found in a subset of patients with systemic lupus erythematosus (SLE) but is most famous for its role in mixed connective tissue disease (MCTD). In fact, having high levels of RNP antibodies is one of the defining features of MCTD, a condition that shows overlapping signs of lupus, scleroderma, and polymyositis. RNP antibodies can also show up, though less commonly, in rheumatoid arthritis, systemic sclerosis, and Sjögren’s syndrome.

Unlike Sm antibodies, which are highly specific to lupus, RNP antibodies are broader markers of autoimmunity. They are not specific to any single disease, which means their presence needs to be interpreted along with a person’s symptoms and other lab findings. High levels of RNP antibodies, especially when accompanied by symptoms like swollen fingers, muscle weakness, or Raynaud’s phenomenon (a circulation problem causing fingers to turn white or blue in the cold), raise strong suspicion for MCTD.